Brief: Ryvu Therapeutics Q3 Net Loss 26.6 Mln Zlotys
07/11/2024 05:46
Nov 7 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* Q3 NET LOSS 26.6 MILLION ZLOTYS
* Q3 OPERATING REVENUE 25.0 MILLION ZLOTYS
* Q3 OPERATING LOSS 26.3 MILLION ZLOTYS
Source text: ID:nEM49fbTza
Further company coverage: RVU.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys